INTERNATIONAL PATENT: SUZHOU TRANSCENTA THERAPEUTICS CO., LTD. FILES APPLICATION FOR "ANTI-FGFR2B IMMUNOCONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER"

GENEVA, May 26 -- SUZHOU TRANSCENTA THERAPEUTICS CO., LTD. (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123) filed a patent application (PCT/CN2024/131761) for "ANTI-FGFR2B IMMUNOCONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER" on Nov 13, 2024. With publication no. WO/2025/103358, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Hongjun (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), GU, Yi (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzh...